<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>O, O-acetyldaurisoline(Adau) is a derivative of daurisoline (Dau) </plain></SENT>
<SENT sid="1" pm="."><plain>In cultured PC12 cells, Adau was found to inhibit K+, Bay K8644 and <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi> induced intracellular free calcium concentration increase </plain></SENT>
<SENT sid="2" pm="."><plain>Adau was also shown to protect PC12 cells from <z:mp ids='MP_0005039'>hypoxia</z:mp>-reoxygenation injury with EC50 of 64.3 +/- 12.5 mumol.L-1 by <z:chebi fb="0" ids="53233">MTT</z:chebi> assay </plain></SENT>
<SENT sid="3" pm="."><plain>Adau (2.5, 5 and 10 mg.kg-1, i.v.) administrated 30 min before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> and four-vessel occlusion rats, attenuated the increase of <z:chebi fb="23" ids="18059">lipid</z:chebi> <z:chebi fb="39" ids="44785">peroxide</z:chebi> content and the decrease of SOD activity </plain></SENT>
<SENT sid="4" pm="."><plain>These results show that Adau have significant protective effects against ischemic injury </plain></SENT>
</text></document>